Global high content screening market is anticipated to exhibit lucrative market growth owing to increasing prevalence of chronic diseases such as HIV AIDS, increasing need of determination and study of toxicity in the initial stages of drug discovery. Technological advancements which include incorporation of multicolored fluorescence based reagents and polarization techniques are expected to boost the market growth further. This result in increased stability of new drugs and reduction in drug discovery time hence is expected to further boost the demand for the market.
The global high content screening market is segregated on the basis of end use, product and application. On the basis of product, it is segmented into instruments, consumables, microplates, software and service. On the basis of application, it is divided into target identification & validation; compound profiling, primary & secondary screening. Under end-use segment, there are contract research organizations, academic & research institutes and pharmaceutical & biotechnology companies As of 2014, the high screening instrument segment held the substantial share in high content screening market owing to need for high cost efficient alternatives and technological advancements.
To Get More Details About High Content Screening Market With Toc:
As of 2014, North America held the largest share of the high content screening market owing to various growth factors which includes increasing prevalence of geriatric population and rising incidences of chronic diseases and advanced healthcare infrastructure. Asia Pacific is expected to be the fastest growing owing to rising need of novel drugs, improving healthcare infrastructure and rising number of new market players are anticipated to play a significant role in growth of high content screening market in this region over the forecast period.
Major players of high content screening market are PerkinElmer Inc., Becton, Dickinson and Company, GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Thorlabs, Inc., Genedata AG, Molecular Devices, and Yokogawa Electric Corporation. These companies aim mergers & acquisitions and developing advanced technologies and in order to dominate the high content screening market. For instance, Thermo Fisher Scientific launched New CeLLInsight CX5 high content screening platform for quantitative cell-based imaging which is enabled with true five-color spectral illumination providing access wider range of fluorescent.
View All Market Research Reports Of This Category:
About Grand View Research
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519